Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia

blast phase chronic myelogenous leukemia, bcr-abl1 positive, recurrent acute biphenotypic leukemia, recurrent acute lymphoblastic leukemia, recurrent acute myeloid leukemia, recurrent chronic myelogenous leukemia, bcr-abl1 positive, recurrent t-cell prolymphocytic leukemia, refractory acute biphenotypic leukemia, refractory acute lymphoblastic leukemia, refractory acute myeloid leukemia, refractory chronic myelogenous leukemia, bcr-abl1 positive, refractory t-cell prolymphocytic leukemia, interventional